Aspira Pathlab & Diagnostics informs about compliance certificate

10 Apr 2023 Evaluate
Aspira Pathlab & Diagnostics has informed that it enclosed Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, for the quarter ended 31st March, 2023, as received from Link Intime India, the Registrar and Share Transfer Agent (RTA) of the Company.

The above information is a part of company’s filings submitted to BSE.

Aspira Pathlab&Diagn Share Price

55.85 1.10 (2.01%)
30-Mar-2026 10:09 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7432.75
Max Healthcare Inst 954.40
Narayana Hrudayalay 1621.25
Aster DM Healthcare 651.10
Global Health 974.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×